Featured News
625Wire StoriesGenexine’s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer
Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA®(pembrolizumab) demonstrates anti-tumor benefit in heavily pre-treated,...
- 493Wire Stories
BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$bgne #beigene—BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing...
- 509News
Temus poised to support transformation of enterprises and public sector to shape Singapore’s digital future
In tandem with the growth of Singapore’s digital footprint, Temus aims to expand its 200-strong workforce by five-fold over the next three...
- 517Wire Stories
Dave & Buster’s Reports Second Quarter 2022 Financial Results
DALLAS, Sept. 07, 2022 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and...
- 702Wire Stories
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia...
- 539Wire Stories
GE Aviation opens new Asia-Pacific Service Centre in Australia
BRISBANE, Australia–(BUSINESS WIRE)–GE Aviation announced the opening a new state-of-the-art facility in Australia to provide maintenance, repair and overhaul services for customers...
- 613Wire Stories
Dr. Reddy’s Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Affordablemedicines–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries...
- 438Wire Stories
Outlook on the Personal Flotation Devices Global Market to 2026 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Personal Flotation Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the personal...
- 524Wire Stories
Atlas Announces a Strategic Partnership with Blockless to Empower the Next-gen Dapps and Builders
SINGAPORE–(BUSINESS WIRE)–Atlas Technology (Atlas), a business-to-protocol innovator who provides a full suite of infrastructure for protocols building in the Web3 ecosystem, announces...
- 528Wire Stories
Liquidnet Enhances VWAP Trading With New VWAP Cross Offering
Liquidnet’s VWAP Cross brings pre-market trading capability to Hong Kong, Japan and Australia HONG KONG–(BUSINESS WIRE)–Liquidnet, a leading technology-driven agency execution specialist,...
- 507Wire Stories
Eye Care Products Markets in China: Demand to Grow at 8% Through 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Care Products Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Eye Care Products has...
